Eiger Biopharmaceuticals

Eiger BioPharmaceuticals is a late stage biopharmaceutical company focused on bringing to market product candidates for the treatment of rare diseases. The company's pipeline includes four Phase 2 development programs addressing four distinct orphan diseases.The pipeline includes lonafarnib for Hepatitis Delta Virus (HDV), Pegylated interferon lambda (lambda) for treating HDV, exendin 9-39 for Post-Bariatric Hypoglycemia, and ubenimex for lymphedema. Lonafarnib for the treatment of HDV infection and Exendin 9-39 for the treatment of hyperinsulinemic hypoglycemia have been granted orphan drug designation by the U.S. Food and Drug Administration and European Medicines Agency.
  • TickerEIGR
  • ISINUS28249U1051
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for EIGR

ValuEngine Rating and Forecast Report for EIGR

Liana Moussatos ...
  • Shveta Dighe

Q1 Financials and Regulatory Guidance Upcoming for Avexitide

ValuEngine Rating and Forecast Report for EIGR

ValuEngine Rating and Forecast Report for EIGR

Liana Moussatos ...
  • Shveta Dighe

Q1 Financials and Regulatory Guidance Upcoming for Avexitide

3 directors bought/maiden bought

Three Directors at Eiger BioPharmaceuticals Inc bought/maiden bought 7,250 shares at between 11.030USD and 11.099USD. The significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is...

ValuEngine Rating and Forecast Report for EIGR

ValuEngine Rating and Forecast Report for EIGR

ValuEngine Rating and Forecast Report for EIGR

ValuEngine Rating and Forecast Report for EIGR

ValuEngine Rating and Forecast Report for EIGR

ValuEngine Rating and Forecast Report for EIGR

ValuEngine Rating and Forecast Report for EIGR

ValuEngine Rating and Forecast Report for EIGR

ValuEngine Rating and Forecast Report for EIGR

ValuEngine Rating and Forecast Report for EIGR

ResearchPool Subscriptions

Get the most out of your insights

Get in touch